Training as a doctoral student through extensive stem cell research using the most advanced flow cytometry technologies in Dublin

Operation co-funded by EU cohesion policy (European Social Fund (ESF)) under the programme EU Structural Funds Investments - LT - ERDF/ESF/CF/YEI (2014LT16MAOP001), managing authority: Finansų ministerija. The source names no beneficiary for this operation. Location: Vilnius County (NUTS LT011); Lithuania. Budget: total eligible expenditure EUR 6,802.33; EU co-financing EUR 6,802.33 (co-financing rate 100%), as stated by the source. Runs 2020-10-07 to 2021-03-31. Source: Kohesio, EU cohesion policy projects managed by national and regional authorities (not CORDIS); selected because its summary names quantum technology. Summary from Kohesio (English machine translation by the source): Osteoarthritis (OA) is a degenerative cartilage joint disease, usually due to the weak ability of the cartilage to repair damage in case of injuries or other injuries. There is currently no effective OA treatment, and there is therefore a huge need to develop a reliable diagnostic and prognostic research algorithm that will help detect early OAs and encourage the development of new therapeutic strategies. Two potential ways to manage cartilage degeneration are human bone marrow mesenchimic stem cell therapy (CSFL) as well as early cartilage degradation biomarkers in search of management options for this process. Flow cytometry and multiplexing platforms are widely used for the characterisation and purification of CČMKL and for the analysis of cartilage biomarkers, where fluorescent nanoparticles (e.g. quantum dots) can be used in one measurement to observe several markers related to the disease. The aim of this trip is to learn multiplexing and the latest generation of flow cytometry technologists by identifying KČMKL and cartilage degradation markers. The work will be done at the UCD Conway Institute, where world-recognised flow cytometry and multiplexing experts work. During the study, the peculiarities of applying innovative fluorescent nanoparticles will be mastered using advanced flow cytometry and multiplexing technologies. Good quality enrichment of the CSFSF population, detection of cartilage degradation proteins, isolation and identification of extracellular vesiculars collected from cartilage explanations and VCSFL using fluorescent markers against specific antigens will be developed. This visit would provide an opportunity to master the latest methods of flow cytometry and nanostructure multiplexing, and results will contribute to the development of new technologies of clinically relevant OA diagnostic and treatment strategies. Also, the link between IMC and UCD Conway researchers will be strengthened, which will boost the development of further [shortened; the full text is on the Kohesio page]

Original source.

Source: Kohesio (EU cohesion policy projects), European Commission, Directorate-General for Regional and Urban Policy (DG REGIO). Retrieved 2026-10-21. Licence: CC0 1.0 (Cohesion Open Data Platform, dataset 2014-2020 Kohesio projects). Selected metadata, adapted presentation; the publisher's record is authoritative. No endorsement by the source is implied. Licence: public domain dedication (CC0 1.0).

AI-assisted summary: The operation, co-funded by the EU's cohesion policy, focuses on doctoral training in stem cell research using advanced flow cytometry technologies in Dublin. It runs from October 7, 2020, to March 31, 2021, with a total budget of EUR 6,802.33. Suggested technology pillar: enabling. Generated by AI from the public source text; it may contain errors and the original source is authoritative.